Ardent Clinical Research Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
About Ardent Clinical Research Services
Ardent Clinical Research Services Private Limited (ACRSPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 September 2021 (Three years and five months 16 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chandu Devanpalli and Swati Kurandale serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300TG2021PTC154680
- Company No.
154680
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Sep 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Ardent Clinical Research Services?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandu Devanpalli  | Director | 06-Sep-2021 | Current |
| Swati Kurandale | Director | 20-Sep-2024 | Current |
Financial Performance of Ardent Clinical Research Services.
Ardent Clinical Research Services Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ardent Clinical Research Services?
Unlock access to Ardent Clinical Research Services's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
St Source Transcript Private LimitedChandu Devanpalli and Swati Kurandale are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ardent Clinical Research Services?
Unlock and access historical data on people associated with Ardent Clinical Research Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ardent Clinical Research Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ardent Clinical Research Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
